IBDeditorials.com: Editorials, Political Cartoons, and Polls from Investor's Business Daily -- Shovel-Ready Health Care:
"...in the United Kingdom, where the National Institute for Health and Clinical Excellence ruled against the use of two drugs, Lapatinib and Sutent, that prolong the life of those with certain forms of breast and stomach cancer. It's no surprise, then, to discover that while breast cancer in America has a 25% mortality rate, in Britain it's almost double at 46%. Prostate cancer is fatal to 19% of American men who get it. In Britain, it kills 57% of those it strikes.
The health care bureaucracy is just as ugly in North America. Sally Pipes, a Canadian who heads the Pacific Research Institute, wrote in these pages on July 2 that in 2008, 'the average Canadian waited 17.3 weeks from the time his general practitioner referred him to a specialist until he actually received treatment.'"